Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

516 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
Isomoto H, Inoue K, Furusu H, Enjoji A, Fujimoto C, Yamakawa M, Hirakata Y, Omagari K, Mizuta Y, Murase K, Shimada S, Murata I, Kohno S. Isomoto H, et al. Aliment Pharmacol Ther. 2003 Jul 1;18(1):101-7. doi: 10.1046/j.1365-2036.2003.01659.x. Aliment Pharmacol Ther. 2003. PMID: 12848631 Free article. Clinical Trial.
Low prevalence of Helicobacter pylori in individuals with HTLV-I infection.
Isomoto H, Mizuta Y, Fukushima K, Takeshima F, Miyazaki M, Murase K, Omagari K, Maeda T, Kamihira S, Tomonaga M, Kohno S. Isomoto H, et al. Eur J Gastroenterol Hepatol. 1999 May;11(5):497-502. doi: 10.1097/00042737-199905000-00006. Eur J Gastroenterol Hepatol. 1999. PMID: 10755252
Implication of NF-kappaB in Helicobacter pylori-associated gastritis.
Isomoto H, Mizuta Y, Miyazaki M, Takeshima F, Omagari K, Murase K, Nishiyama T, Inoue K, Murata I, Kohno S. Isomoto H, et al. Am J Gastroenterol. 2000 Oct;95(10):2768-76. doi: 10.1111/j.1572-0241.2000.02304.x. Am J Gastroenterol. 2000. PMID: 11051346
516 results